HALO
Price
$53.15
Change
+$0.04 (+0.08%)
Updated
Jun 18 closing price
Capitalization
6.55B
53 days until earnings call
KZR
Price
$4.46
Change
+$0.37 (+9.05%)
Updated
Jun 18 closing price
Capitalization
32.58M
Interact to see
Advertisement

HALO vs KZR

Header iconHALO vs KZR Comparison
Open Charts HALO vs KZRBanner chart's image
Halozyme Therapeutics
Price$53.15
Change+$0.04 (+0.08%)
Volume$1.4M
Capitalization6.55B
Kezar Life Sciences
Price$4.46
Change+$0.37 (+9.05%)
Volume$50.53K
Capitalization32.58M
HALO vs KZR Comparison Chart in %
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HALO vs. KZR commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Buy and KZR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (HALO: $53.15 vs. KZR: $4.09)
Brand notoriety: HALO and KZR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 61% vs. KZR: 4%
Market capitalization -- HALO: $6.55B vs. KZR: $32.58M
HALO [@Biotechnology] is valued at $6.55B. KZR’s [@Biotechnology] market capitalization is $32.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileKZR’s FA Score has 1 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • KZR’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 4 TA indicator(s) are bullish while KZR’s TA Score has 6 bullish TA indicator(s).

  • HALO’s TA Score: 4 bullish, 3 bearish.
  • KZR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KZR is a better buy in the short-term than HALO.

Price Growth

HALO (@Biotechnology) experienced а -1.30% price change this week, while KZR (@Biotechnology) price change was -12.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

HALO is expected to report earnings on Aug 12, 2025.

KZR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($6.55B) has a higher market cap than KZR($32.6M). HALO YTD gains are higher at: 11.169 vs. KZR (-39.137). HALO has higher annual earnings (EBITDA): 705M vs. KZR (-76.06M). HALO has more cash in the bank: 748M vs. KZR (114M). KZR has less debt than HALO: KZR (14.1M) vs HALO (1.51B). HALO has higher revenues than KZR: HALO (1.08B) vs KZR (0).
HALOKZRHALO / KZR
Capitalization6.55B32.6M20,089%
EBITDA705M-76.06M-927%
Gain YTD11.169-39.137-29%
P/E Ratio14.14N/A-
Revenue1.08B0-
Total Cash748M114M656%
Total Debt1.51B14.1M10,688%
FUNDAMENTALS RATINGS
HALO vs KZR: Fundamental Ratings
HALO
KZR
OUTLOOK RATING
1..100
8218
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
41100
SMR RATING
1..100
1297
PRICE GROWTH RATING
1..100
5863
P/E GROWTH RATING
1..100
86100
SEASONALITY SCORE
1..100
9565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KZR's Valuation (12) in the Biotechnology industry is somewhat better than the same rating for HALO (75). This means that KZR’s stock grew somewhat faster than HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (41) in the Biotechnology industry is somewhat better than the same rating for KZR (100). This means that HALO’s stock grew somewhat faster than KZR’s over the last 12 months.

HALO's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for KZR (97). This means that HALO’s stock grew significantly faster than KZR’s over the last 12 months.

HALO's Price Growth Rating (58) in the Biotechnology industry is in the same range as KZR (63). This means that HALO’s stock grew similarly to KZR’s over the last 12 months.

HALO's P/E Growth Rating (86) in the Biotechnology industry is in the same range as KZR (100). This means that HALO’s stock grew similarly to KZR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HALOKZR
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMTC0.690.04
+5.80%
NeuroOne Medical Technologies Corp
FFIN35.10N/A
N/A
First Financial Bankshares
BMRC21.50-0.01
-0.05%
Bank of Marin Bancorp
KOP31.15-0.47
-1.49%
Koppers Holdings
PAYX150.32-3.36
-2.19%
Paychex

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.08%
AXON - HALO
47%
Loosely correlated
-0.87%
XENE - HALO
45%
Loosely correlated
+0.63%
VIR - HALO
40%
Loosely correlated
+2.16%
ARGX - HALO
36%
Loosely correlated
-0.52%
TECH - HALO
34%
Loosely correlated
+1.27%
More

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with AMRN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
N/A
AMRN - KZR
56%
Loosely correlated
-0.60%
CNTB - KZR
47%
Loosely correlated
-7.40%
SAGE - KZR
36%
Loosely correlated
+0.11%
RAPT - KZR
34%
Loosely correlated
-5.36%
CTMX - KZR
34%
Loosely correlated
-11.34%
More